HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 30 filers reported holding HARPOON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,206,000 | -21.7% | 190,483 | 0.0% | 0.21% | -8.5% |
Q4 2019 | $2,817,000 | -36.2% | 190,483 | -41.1% | 0.23% | -52.2% |
Q3 2019 | $4,418,000 | +5.1% | 323,400 | 0.0% | 0.49% | +76.3% |
Q2 2019 | $4,205,000 | +37.3% | 323,400 | 0.0% | 0.28% | +42.6% |
Q1 2019 | $3,062,000 | – | 323,400 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |